Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts
New York, January 7, 2026, 20:54 (EST) — Market closed Bristol Myers Squibb shares rose 4.2% to $56.72 on Wednesday after UBS upgraded the drugmaker to buy and lifted its price target to $65 from $46. TipRanks The call matters now because big drugmakers are trying to convince investors they can bridge the next few years of patent losses without…